Inactivation of the ABC transporter ATPase gene in Brucella abortus strain 2308 attenuated the virulence of the bacteria

Veterinary Microbiology

Volumn 164, Issue 3-4, 2013, Pages 322-329

  Zhang, Min ^a,b   Han, Xiangan ^b   Liu, Haiwen ^b   Tian, Mingxing ^b   Ding, Chan ^b   Song, Jun ^b   Sun, Xiaoqing ^b   Liu, Zongping ^a   Yu, Shengqing ^b  

^a YANGZHOU UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Brucella abortus; Gene inactivation; The ABC transporter ATPase gene; Virulence

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER ATPASE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; BRUCELLA VACCINE; CRYSTAL VIOLET; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

AGGLUTINATION TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BROTH DILUTION; BRUCELLA ABORTUS; BRUCELLOSIS; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GROWTH RATE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOLECULE; MOUSE; NONHUMAN; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; STAINING; TRYPTICASE SOY MEDIUM; WILD TYPE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BACTERIAL VACCINES; BRUCELLA ABORTUS; BRUCELLOSIS; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC COMPLEMENTATION TEST; IMMUNIZATION; MACROPHAGES; MICE; MICE, INBRED BALB C; RANDOM ALLOCATION; SEQUENCE DELETION; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; MUS; NEGIBACTERIA;

EID: 84877127933     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.02.017     Document Type: Article

References (29)

1. Aderem A. Phagocytosis and the inflammatory response. J. Infect. Dis. 2003, 187:S340-S345.
2. Allen C.A., Adams L.G., Ficht T.A. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect. Immun. 1998, 66:1008-1016.
3. Celli J. Surviving inside a macrophage: the many ways of Brucella. Res. Microbiol. 2006, 157:93-98.
4. Conde-álvarez R., Arce-Gorvel V., Iriarte M., Manček-Keber M., Barquero-Calvo E., Palacios-Chaves L., Chacón-Díaz C., Chaves-Olarte E., Martirosyan A., von Bargen K. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. PLoS Pathogens 2012, 8:e1002675.
5. Fretin D., Fauconnier A., Köhler S., Halling S., Leonard S., Nijskens C., Ferooz J., Lestrate P., Delrue R.M., Danese I. The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection. Cell Microbiol. 2005, 7:687-698.
6. Fugier E., Pappas G., Gorvel J.P. Virulence factors in brucellosis: implications for aetiopathogenesis and treatment. Expert Rev. Mol. Med. 2007, 9:1-10.
7. Godfroid F., Cloeckaert A., Taminiau B., Danese I., Tibor A., de Bolle X., Mertens P., Letesson J.J. Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of Brucella melitensis 16M (wbk). Res. Microbiol. 2000, 151:655-668.
8. Godfroid F., Taminiau B., Danese I., Denoel P., Tibor A., Weynants V., Cloeckaert A., Godfroid J., Letesson J.J. Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages. Infect. Immun. 1998, 66:5485-5493.
9. Goldstein J., Hoffman T., Frasch C., Lizzio E., Beining P., Hochstein D., Lee Y., Angus R., Golding B. Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infect. Immun. 1992, 60:1385-1389.
10. Gorvel J.P., Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet. Microbiol. 2002, 90:281-297.
11. Han D., Huang G., Lin L., Warner N., Gim J., Jewett A. Expression of MHC Class II, CD70, CD80, CD86 and pro-inflammatory cytokines is differentially regulated in oral epithelial cells following bacterial challenge. Oral Microbiol. Immunol. 2003, 18:350-358.
12. Handunnetthi L., Ramagopalan S.V., Ebers G.C., Knight J.C. Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immu. 2009, 11:99-112.
13. Hoffmann E., Houle J. Failure of Brucella abortus lipopolysaccharide (LPS) to activate the alternative pathway of complement. Vet. Immunol. Immunopathol. 1983, 5:65-76.
14. Keenleyside W.J., Whitfield C. Genetics and biosynthesis of lipopolysaccharide O-antigens. Endotoxin Health Dis. 1999, 331-358.
15. Kovach M., Phillips R., Elzer P., Roop R. pBBR 1 MCS: a broad-host-range cloning vector. Biotechniques 1994, 16:800-802.
16. Lapaque N., Moriyon I., Moreno E., Gorvel J.P. Brucella lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 2005, 8:60-66.
17. Martínez-Núñez C., Altamirano-Silva P., Alvarado-Guillén F., Moreno E., Guzmán-Verri C., Chaves-Olarte E. The two-component system BvrR/BvrS regulates the expression of the type IV secretion system VirB in Brucella abortus. J. Bacteriol. 2010, 192:5603-5608.
18. Martirosyan A., Moreno E., Gorvel J.P. An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol. Rev. 2011, 240:211-234.
19. Marx C.J. Development of a broad-host-range sacB-based vector for unmarked allelic exchange. BMC Res. Notes 2008, 1:1.
20. Moreno E., Berman D., Boettcher L. Biological activities of Brucella abortus lipopolysaccharides. Infect. Immun. 1981, 31:362-370.
21. Naroeni A., Porte F. Role of cholesterol and the ganglioside GM1 in entry and short-term survival of Brucella suis in murine macrophages. Infect. Immun. 2002, 70:1640-1644.
22. Pei J., Ficht T.A. Brucella abortus rough mutants are cytopathic for macrophages in culture. Infect. Immun. 2004, 72:440-450.
23. Pei J., Turse J.E., Wu Q., Ficht T.A. Brucella abortus rough mutants induce macrophage oncosis that requires bacterial protein synthesis and direct interaction with the macrophage. Infect. Immun. 2006, 74:2667-2675.
24. Philippe N., Alcaraz J.P., Coursange E., Geiselmann J., Schneider D. Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid 2004, 51:246-255.
25. Prieto C.I., Rodriguez M.E., Bosch A., Chirdo F.G., Yantorno O.M. Whole-bacterial cell enzyme-linked immunosorbent assay for cell-bound Moraxella bovis pili. Vet. Microbiol. 2003, 91:157-168.
26. Sun Y., Ding N., Ding S.S., Yu S., Meng C., Chen H., Qiu X., Zhang S., Yu Y., Zhan Y. Goose RIG-I functions in innate immunity against newcastle disease virus infections. Mol. Immunol. 2013, 53:321-327.
27. Wang Z., Zhang L., Qiao A., Watson K., Zhang J., Fan G.H. Activation of CXCR4 triggers ubiquitination and down-regulation of major histocompatibility complex class I (MHC-I) on epithelioid carcinoma HeLa cells. J. Biol. Chem. 2008, 283:3951-3959.
28. White P.G., Wilson J. Differentiation of smooth and nonsmooth colonies of Brucellae. J. Bacteriol. 1951, 61:239-240.
29. Zhou Z., White K.A., Polissi A., Georgopoulos C., Raetz C.R.H. Function of Escherichia coli MsbA, an essential ABC family transporter, in lipid A and phospholipid biosynthesis. J. Biol. Chem. 1998, 273:12466-12475.